FGF23 and type 1 diabetes mellitus: Finally, we acknowledge that both FGF23 and α-klotho are not currently used in clinical practice; however, we believe that further research is needed to gain further insight in the translational and clinical significance of the relationship between α-klotho and subclinical atherosclerosis in T1D, and the potential application of this protein as a biomarker.